Transition report pursuant to Rule 13a-10 or 15d-10

Statements of Operations

v3.22.1
Statements of Operations - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2021
Mar. 31, 2021
Operating expenses:    
Research and development $ 2,496 $ 3,540
Selling, general and administrative 14,367 15,812
Total operating expenses 16,863 19,352
Loss from operations (16,863) (19,352)
Other income (expense):    
Other income 7
Other expense (55) (56)
Interest expense (7) (3,196)
Loss on exchange of notes payable for common stock and warrants (1,527)
Gain (loss) on extinguishment of debt 7 (14,257)
Gain on forgiveness of PPP loan 431  
Change in fair value of warrant liability (2,361)
Change in fair value of derivative liability (13)
Total other income (expense) 376 (21,403)
Loss before income taxes (16,487) (40,755)
Income tax expense
Net loss $ (16,487) $ (40,755)
Net loss per share, basic and diluted: (in Dollars per share) $ (1.13) $ (4.6)
Weighted average shares outstanding, basic and diluted: (in Shares) 14,596,019 8,851,151